
In the second episode with Emory’s Gavin Harris, MD, he offers some insights about treating patients with the Andes virus, including supportive care as well as investigational antivirals.
Harris is an assistant professor of Medicine at the Emory University School of Medicine in the Division of Pulmonary and Critical Care Medicine & the Division of Infectious Diseases. He is the director of Education and Outreach at Emory’s Serious Communicable Diseases Program, a critical care co-liaison to Emory’s biocontainment unit, the Serious Communicable Diseases Unit, the co-chair of the joint US Viral Hemorrhagic Fevers Critical Care Guidance Task Force, and a member of the World Health Organization Technical Advisory Group on Therapeutics Prioritization.

In the second episode with Emory’s Gavin Harris, MD, he offers some insights about treating patients with the Andes virus, including supportive care as well as investigational antivirals.

Emory’s Gavin Harris, MD, discusses how getting patients this type of treatment is essential to reducing the severity of disease, as well as adapting the four “I’s” algorithm in dealing with high-consequence infectious disease outbreaks.

Biocontainment, including the most recent threat of highly pathogenic avian influenza, demands we continue to finance research, and continue cooperation with important organizations like the WHO.

In the third installment of our series on preparedness, Gavin Harris, MD, discusses the principles and challenges of biorisk management, focusing on infectious disease threats and containment strategies.

As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.

May 23rd 2026